BioMarin Pharmaceutical

Aktienkurs
58.13
Täglich Wechseln
0.98 1.71%
Monatlich
-5.19%
Jährlich
-9.07%
Q1 Prognose
56.35




Ebit Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Amgen USD 3.96B 464M 2025-12
Bayer EUR -399M 363M 2025-09
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Gilead Sciences USD 3.51B 810M 2025-09
Incyte USD 431.31M 120.49M 2025-09
Insmed USD -261.35M 7.48M 2025-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Moderna USD -260M 557M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 3.74B 2.23B 2025-09
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
United Therapeutics USD 389.3M 112.4M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


BioMarin Pharmaceutical - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.